In Tomoyukiv’s research [40], the data source was the Japanese Adverse Event Report database, and the outcomes of muscle toxicity were only defined by the elevation of creatine phosphokinase (CPK) levels, myopathy, and/or rhabdomyolysis. The gene discussed is PIK3C2A; the disease is rhabdomyolysis.